Kaneka Medical America, LLC
LIPOSORBER® is indicated for use in clinically diagnosed Familial Hypercholesterolemia patients with either documented PAD or CAD, if: LDL-C > 70 mg/dL or Lp(a)>60 mg/dL (or 130 nmol/L) and diet and maximum tolerable combination lipid-lowering drug therapies have failed to achieve established therapeutic targets per guidelines.